Prince Pharmaceutical Co (ROCO:6935) ROCE % : 2.89% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Prince Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Prince Pharmaceutical Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.89%.

Prince Pharmaceutical Co ROCE % Historical Data

The historical data trend for Prince Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prince Pharmaceutical Co ROCE % Chart

Prince Pharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

0.36

-4.15

-0.26

6.64

2.56

Prince Pharmaceutical Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			1.93	8.27	5.00	2.14	2.89

Prince Pharmaceutical Co ROCE % Calculation

Prince Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	29.626	/	( ( (1304.289 - 190.16)	+	(1410.935 - 211.942) )	/ 2 )
	=	29.626	/	( (1114.129	+	1198.993)	/ 2 )
	=	29.626	/	1156.561
	=	2.56 %

Prince Pharmaceutical Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	34.538	/	( ( (1374.948 - 183.646)	+	(1410.935 - 211.942) )	/ 2 )
	=	34.538	/	( ( 1191.302	+	1198.993 )	/ 2 )
	=	34.538	/	1195.1475
	=	2.89 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Prince Pharmaceutical Co (ROCO:6935) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Prince Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Prince Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Prince Pharmaceutical Co (ROCO:6935) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prince Pharmaceutical Co Ltd (ROCO:6935) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 168, Keyunnan Road, Huwei Town, Yunlin, TWN, 632

Website

https://www.prince-pharm.com.tw

Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe, and other regions.

Prince Pharmaceutical Co (ROCO:6935) Headlines

No Headlines